Sonorous Neurovascular announced that the FDA has granted Breakthrough Device designation for its BosSTENT, a braided, ...

AngioDynamics, Inc. and The PERT Consortium announced the launch of the ALPHA-PE Research Fund, an investigator-led initiative ...

Rampart, an Alabama-based medical device company focused on interventional radiation safety, announced the appointment of Gerha ...

Avantec Vascular, a Nipro company, announced FDA 510(k) clearance of its thrombectomy system, which is intended for the treatme ...

Delivering intra-arterial alteplase after successful mechanical thrombectomy improved functional recovery in patients with ...

Isabel Newton, MD, PhD, has been named Chief Medical Officer of Boston Scientific's Interventional Oncology and Embolizatio ...

Endospan, a privately held, Israel-based company focused on the endovascular repair of aortic arch disease, announced 1-year ...

GE HealthCare announced that its Allia Moveo imaging platform for the interventional suite has received FDA 510(k) clearance an ...

Pulmonary embolism (PE) remains a major cause of cardiovascular morbidity and mortality worldwide. It occurs when thrombotic material—most often ...

As an interventional radiologist at Palmetto General Hospital, I have over 15 years of experience treating venous thromboembolic disease and have comp ...

Advancing PE intervention with the AVENTUS Thrombectomy System, a streamlined solution designed for procedural efficiency, seamless workflow, and safe, reliable outcomes.